论文部分内容阅读
目的 :探究沐舒坦联合地塞米松治疗新生儿童重症吸入性肺炎的疗效。方法 :随机选取我院2015年4月-2016年4月120例新生儿童重症吸入性肺炎患者,随机分成两组,即对照组和实验组,每组60人。对照组的60例患儿在常规治疗的基础上进行地塞米松治疗。实验组的60例患儿在常规治疗的基础上进行沐舒坦联合地塞米松治疗。采用统计学软件SPSS10.0统计分析两组患儿的临床疗效、机械通气、通气时间、氧疗时间、住院时间等指标。结论 :采用地塞米松治疗的对照组60例患儿总有效29人(48.3%),而采用沐舒坦联合地塞米松治疗的实验组60例患儿中治总有效49(81.7%),实验组的总有效率明显高于对照组,同时实验组的机械通气、通气时间、氧疗时间以及住院时间等指标均低于对照组。说明采用沐舒坦联合地塞米松治疗新生儿童重症吸入性肺炎疗效优于单纯使用地塞米松治疗新生儿童重症吸入性肺炎,可以在临床进一步推广。
Objective: To investigate the efficacy of mucosolvan combined with dexamethasone in the treatment of infantile severe inhalant pneumonia. Methods: A total of 120 neonates with severe aspiration pneumonia in our hospital from April 2015 to April 2016 were randomly selected and divided into two groups at random: control group and experimental group, with 60 in each group. Sixty children in the control group were treated with dexamethasone on a routine basis. 60 patients in the experimental group were treated with mucosolvan and dexamethasone on the basis of routine treatment. Using statistical software SPSS10.0 statistical analysis of two groups of children with clinical efficacy, mechanical ventilation, ventilation time, oxygen therapy time, hospitalization time and other indicators. CONCLUSIONS: Sixty patients in the control group treated with dexamethasone had a total effective rate of 29 (48.3%) compared with 49 (81.7%) in the 60 treatment groups treated with mucosolvan plus dexamethasone. Group total effective rate was significantly higher than the control group, while the experimental group of mechanical ventilation, ventilation time, oxygen therapy time and hospital stay indicators were lower than the control group. Description of the combination of mucosolvan and dexamethasone treatment of neonatal pneumonia in children with better than simple dexamethasone treatment of neonatal severe aspiration pneumonia, can be further promoted in the clinic.